InsidersTradesSigma
基于 5 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Lin Sue-Jean, 董事. Insider active across 2 companies, notably Arcutis Biotherapeutics, Inc.. Aggregated, 9 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €676k. Activity tracked since 1 June 2022. The latest transaction was filed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Sue-Jean Lin is a Board Member at Arcutis Biotherapeutics, Inc. She participates in the governance of the company, contributing to strategic decision-making and the overall direction of the organization. Her experience in the biopharmaceutical sector is an asset for Arcutis in achieving its objectives.